Time lines are different
Preclinical studies in animals have consistently demonstrated that BPC-157 offers significant healing benefits across various organs and systems with few reported side effects
(2008) Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system
Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, Bhanot S, Monia BP, Li YX, Diehl AM (2007) Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis
Most community use is split between topical creams or serums and subcutaneous injection
Now I share that research at MyBioHack to help others find their own answers